2022 annual financial data
Estrella Immunopharma 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -1,569,530 USD and net income was -996,104 USD.
Operating cash flow was -1,043,848 USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,569,530 USD
- Net income
- -996,104 USD
- Operating cash flow
- -1,043,848 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Estrella Immunopharma financial years